← Back to catalogue
Manifold Kit
EUDAMEDClass IIa (EU MDR)
Ref AM0352FModel AM0250, AM0251, AM0350, AM0351, AM0351A, AM0351C, AM0351D, AM0352, AM0352A, AM0352E, AM0352G, AM0352J, AM0353, AM0352H, AM0351-G, AM0352F, AM0352F-1, AM0351F, AM0352L, AM0352M, AM0352N, AM0352P, AM0352B, AM0352C, AM0352D.
Identity
- Device Name
- Manifold Kit EUDAMED
- Model / Reference
- AM0250, AM0251, AM0350, AM0351, AM0351A, AM0351C, AM0351D, AM0352, AM0352A, AM0352E, AM0352G, AM0352J, AM0353, AM0352H, AM0351-G, AM0352F, AM0352F-1, AM0351F, AM0352L, AM0352M, AM0352N, AM0352P, AM0352B, AM0352C, AM0352D. EUDAMEDAM0352F EUDAMED
Identifiers
- Primary DI / UDI-DI
- 06950900965418 EUDAMED
- Basic UDI-DI
- 69509009CEMKSA EUDAMED
- EMDN Code
- C010480 ANGIOGRAPHY AND HEMODYNAMICS DEVICES - ACCESSORIES NOT INCLUDED IN OTHER CLASSES EUDAMED
Classification
- Device Class
- Class IIa EUDAMED
- Market of Registration
- Germany EUDAMED
Clinical & Handling
Sterile
Yes
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
Manifold Kit by Shanghai INT Medical Instruments Co., Ltd. — Class IIa — MDR — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 69509009CEMKSA | Class IIa | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Shanghai INT Medical Instruments Co., Ltd.
- EUDAMED SRN
- CN-MF-000009966
- Authorised Representative
- Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001
Sources (1)
- EUDAMED acdfce72-3473-4c81-98c6-6b124b2babb0 61 fields · synced Oct 5, 2026